These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


358 related items for PubMed ID: 8331662

  • 1. Crystallographic binding studies on the allosteric inhibitor glucose-6-phosphate to T state glycogen phosphorylase b.
    Johnson LN, Snape P, Martin JL, Acharya KR, Barford D, Oikonomakos NG.
    J Mol Biol; 1993 Jul 05; 232(1):253-67. PubMed ID: 8331662
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Ternary complex crystal structures of glycogen phosphorylase with the transition state analogue nojirimycin tetrazole and phosphate in the T and R states.
    Mitchell EP, Withers SG, Ermert P, Vasella AT, Garman EF, Oikonomakos NG, Johnson LN.
    Biochemistry; 1996 Jun 11; 35(23):7341-55. PubMed ID: 8652510
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Refined crystal structure of the phosphorylase-heptulose 2-phosphate-oligosaccharide-AMP complex.
    Johnson LN, Acharya KR, Jordan MD, McLaughlin PJ.
    J Mol Biol; 1990 Feb 05; 211(3):645-61. PubMed ID: 2106586
    [Abstract] [Full Text] [Related]

  • 7. The allosteric transition of glycogen phosphorylase.
    Barford D, Johnson LN.
    Nature; 1989 Aug 24; 340(6235):609-16. PubMed ID: 2770867
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Activator anion binding site in pyridoxal phosphorylase b: the binding of phosphite, phosphate, and fluorophosphate in the crystal.
    Oikonomakos NG, Zographos SE, Tsitsanou KE, Johnson LN, Acharya KR.
    Protein Sci; 1996 Dec 24; 5(12):2416-28. PubMed ID: 8976550
    [Abstract] [Full Text] [Related]

  • 11. Evolution of allosteric control in glycogen phosphorylase.
    Hudson JW, Golding GB, Crerar MM.
    J Mol Biol; 1993 Dec 05; 234(3):700-21. PubMed ID: 8254668
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Partial activation of muscle phosphorylase by replacement of serine 14 with acidic residues at the site of regulatory phosphorylation.
    Buchbinder JL, Luong CB, Browner MF, Fletterick RJ.
    Biochemistry; 1997 Jul 01; 36(26):8039-44. PubMed ID: 9201951
    [Abstract] [Full Text] [Related]

  • 15. Slow conformational transitions of muscle glycogen phosphorylase b induced by specific ligands.
    Kurganov BI, Schors EI.
    Biochem Mol Biol Int; 1994 May 01; 33(1):65-72. PubMed ID: 8081214
    [Abstract] [Full Text] [Related]

  • 16. Glucose analogue inhibitors of glycogen phosphorylase: from crystallographic analysis to drug prediction using GRID force-field and GOLPE variable selection.
    Watson KA, Mitchell EP, Johnson LN, Cruciani G, Son JC, Bichard CJ, Fleet GW, Oikonomakos NG, Kontou M, Zographos SE.
    Acta Crystallogr D Biol Crystallogr; 1995 Jul 01; 51(Pt 4):458-72. PubMed ID: 15299833
    [Abstract] [Full Text] [Related]

  • 17. [Conformational changes of spin-labeled native and modified phosphorylase B].
    Vul'fson PL, Skolysheva LK, Mikhaĭlova LI, Dudich IV, Timofeev VP.
    Biokhimiia; 1980 Mar 01; 45(3):532-43. PubMed ID: 6246972
    [Abstract] [Full Text] [Related]

  • 18. 1-(3-Deoxy-3-fluoro-beta-d-glucopyranosyl) pyrimidine derivatives as inhibitors of glycogen phosphorylase b: Kinetic, crystallographic and modelling studies.
    Tsirkone VG, Tsoukala E, Lamprakis C, Manta S, Hayes JM, Skamnaki VT, Drakou C, Zographos SE, Komiotis D, Leonidas DD.
    Bioorg Med Chem; 2010 May 15; 18(10):3413-25. PubMed ID: 20430629
    [Abstract] [Full Text] [Related]

  • 19. Comparison of AMP and NADH binding to glycogen phosphorylase b.
    Stura EA, Zanotti G, Babu YS, Sansom MS, Stuart DI, Wilson KS, Johnson LN, Van de Werve G.
    J Mol Biol; 1983 Oct 25; 170(2):529-65. PubMed ID: 6415289
    [Abstract] [Full Text] [Related]

  • 20. Structural basis of the synergistic inhibition of glycogen phosphorylase a by caffeine and a potential antidiabetic drug.
    Tsitsanou KE, Skamnaki VT, Oikonomakos NG.
    Arch Biochem Biophys; 2000 Dec 15; 384(2):245-54. PubMed ID: 11368311
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.